LYTIR

Insider · SEC Form 4 · Chief Executive Officer

OYLER JOHN

In the 12 months to Nov 8, 2026, on the open market: sold $295.9M of ONC. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $295.9M in total.Jun: Insider sales $2.4MJul: Insider sales $207.0MAug: Insider sales $86.5MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $295.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ONCSold: BeOne Medicines Ltd. Aug 12, 2026 54,892 shares filed Aug 12, 2026 5 transactions 10b5-1 plan filing $19.7M
  2. ONCSold: BeOne Medicines Ltd. Aug 11, 2026 70,907 shares filed Aug 12, 2026 9 transactions 10b5-1 plan filing $25.7M
  3. ONCSold: BeOne Medicines Ltd. Aug 10, 2026 115,011 shares filed Aug 12, 2026 10 transactions 10b5-1 plan filing $41.2M
  4. ONCSold: BeOne Medicines Ltd. Jul 21, 2026 61,397 shares filed Jul 22, 2026 5 transactions 10b5-1 plan filing $19.5M
  5. ONCSold: BeOne Medicines Ltd. Jul 20, 2026 48,316 shares filed Jul 22, 2026 9 transactions 10b5-1 plan filing $15.1M
  6. ONCSold: BeOne Medicines Ltd. Jul 17, 2026 64,628 shares filed Jul 17, 2026 9 transactions 10b5-1 plan filing $20.2M
  7. ONCSold: BeOne Medicines Ltd. Jul 16, 2026 166,597 shares filed Jul 17, 2026 12 transactions 10b5-1 plan filing $53.0M
  8. ONCSold: BeOne Medicines Ltd. Jul 15, 2026 116,557 shares filed Jul 17, 2026 5 transactions 10b5-1 plan filing $36.4M
  9. ONCSold: BeOne Medicines Ltd. Jul 14, 2026 145,861 shares filed Jul 14, 2026 6 transactions 10b5-1 plan filing $44.6M
  10. ONCSold: BeOne Medicines Ltd. Jul 13, 2026 48,520 shares filed Jul 14, 2026 7 transactions 10b5-1 plan filing $14.8M
  11. ONCSold: BeOne Medicines Ltd. Jul 10, 2026 11,698 shares filed Jul 14, 2026 8 transactions 10b5-1 plan filing $3.5M
  12. ONCSold: BeOne Medicines Ltd. Jun 23, 2026 3,410 shares filed Jun 25, 2026 3 transactions filing $934K
  13. ONCSold: BeOne Medicines Ltd. Jun 16, 2026 3,693 shares filed Jun 18, 2026 3 transactions filing $981K
  14. ONCSold: BeOne Medicines Ltd. Jun 11, 2026 1,949 shares filed Jun 15, 2026 4 transactions filing $501K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • ONC: option exercise or conversion (code M), 11 entries, Jul 10 to Jul 20, 2026
  • ONC: grant or award (code A), 1 entry, Jun 11, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.